home / stock / kprx / kprx news


KPRX News and Press, Kiora Pharmaceuticals Inc. From 07/07/23

Stock Information

Company Name: Kiora Pharmaceuticals Inc.
Stock Symbol: KPRX
Market: NASDAQ
Website: kiorapharma.com

Menu

KPRX KPRX Quote KPRX Short KPRX News KPRX Articles KPRX Message Board
Get KPRX Alerts

News, Short Squeeze, Breakout and More Instantly...

KPRX - New Investing Ideas in Biotech: AGLE, MRTX, SXTP, AZTR, KPRX, RSLS, GENFF

2023-07-07 11:10:00 ET Vancouver, Kelowna, Delta, BC - July 7, 2023 (Investorideas.com Newswire) Investorideas.com , a global news source and expert investing resource, announces its weekly roundup of stocks to watch in Biotech. Today's stocks have been added to our lists of free stock ...

KPRX - Kiora Pharmaceuticals Receives $1.2 Million in Research Tax Credits to Advance the Treatment of Ophthalmic Disease

Encinitas, California--(Newsfile Corp. - July 5, 2023) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) announced its wholly owned subsidiaries have received, in aggregate, $1.2 million related to research tax incentives from the Austrian and Australian governments for research expenditures performed...

KPRX - Life Science Investor Forum: Presentations Now Available for Online Viewing

NEW YORK, June 23, 2023 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from Life Science Investor Forum, held on June 22 nd are now available for online viewing. REGISTER NOW AT : https://...

KPRX - Life Science Investor Forum Agenda Announced for June 22nd

NEW YORK, June 20, 2023 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the Life Science Investor Forum. Individual investors, institutional investors, advisors, and analysts are invited to attend. REGIST...

KPRX - Kiora Pharmaceuticals and Sentrx Animal Care Amend Existing Manufacturing Licensing Agreement for KIO-201

Amendment eliminates $4.75M in near-term milestones Kiora would have owed to Sentrx Sentrx gains access to Kiora's recently issued patents covering the combination of KIO-201 and antibiotics for veterinary use Kiora will receive a royalty on net sales of products covered by licensed patents...

KPRX - Kiora Pharmaceuticals to Present at Upcoming Investor Conferences

Encinitas, California--(Newsfile Corp. - June 14, 2023) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) announced its President & CEO, Brian Strem, Ph.D., will participate in two upcoming investor conferences. The Healthcare Virtual Conference hosted by Maxim Group June 20, 2023 from 10:00 t...

KPRX - Kiora Pharmaceuticals Announces Closing of $6.3 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option

Encinitas, California--(Newsfile Corp. - June 6, 2023) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") today announced the closing of an underwritten public offering for gross proceeds of approximately $6.3 million, which includes full exercise of the underwriter's over-al...

KPRX - IONQ, BIG and MBOT among mid-day movers

2023-06-02 13:27:06 ET Gainers: LAVA Therapeutics N.V. ( LVTX ) +79% . U Power Limited ( UCAR ) +34% . Samsara ( IOT ) +30% . MongoDB ( MDB ) +27% . Digital Ally ( DGLY ) +26% . iHeartMedia ( IHRT ) +24% . The Che...

KPRX - Connect Biopharma, LAVA top healthcare gainers; Kiora, Kymera among losers

2023-06-02 10:02:23 ET Gainers: Connect Biopharma ( CNTB ) +26% . LAVA Therapeutics ( LVTX ) +19% . Panbela Therapeutics ( PBLA ) +18% . Apollomics ( APLM ) +15% .  Rockwell Medical ( RMTI ) +10% . Losers: Kiora Pharm...

KPRX - Kiora Pharmaceuticals stock drops 50% on $5.5M public offering

2023-06-02 09:32:21 ET Kiora Pharmaceuticals ( NASDAQ: KPRX ) stock dropped 50% on Friday after the firm priced an underwritten public offering for gross proceeds of ~$5.5M. The offering is comprised of ~1.4M shares, 3.9K series F convertible preferred shares, 5M class...

Previous 10 Next 10